Hair shedding often appears 23 months after starting treatment, reflecting the delayed timing of the hair growth cycle rather than an immediate reaction to the medication
The efficacy of TRESIBA administered once daily either at the same time each day or at any time each day in adult patients with type 2 diabetes and used in combination with a mealtime insulin or in combination with common oral anti diabetic agents was evaluated in six randomized, open label, treat to target active controlled trials
Clinical trials reported in the European Public Assessment Report (EPAR) showed nausea affecting approximately 44% of patients, diarrhoea (30%), vomiting (24%), constipation (24%), abdominal pain (20%), and dyspepsia (9%)
One small study of breastfeeding mothers using injectable semaglutide detected no traces of the drug in human breast milk
Mick is an optometrist and residency director at the San Francisco VA Medical Center, a clinical professor at UC Berkeley Herbert Wertheim School of Optometry and Vision Science and holds a volunteer faculty appointment at the UC San Francisco department of ophthalmology